Skip to main content
. 2024 Jan 3;11(3):607–617. doi: 10.1002/acn3.51979

Table 4.

NEFL results.

Controls CMTX1 CMT1B CMT2A
NEFL (ng/L) n Mean ± SD (Range) p n Mean ± SD (Range) p n Mean ± SD (Range) p n Mean ± SD (Range) p
Baseline 14 6.6 ± 3.2 (3.5–15.9) NA 21 13.6 ± 4.6 (5.9–20.5) 0.007 21 18.8 ± 8.8 (4.8–38.0) <0.001 20 17.3 ± 5.4 (9.3–29.3) <0.001
Annual change 14 0.3 ± 1.2 (−1.2–3.3) 0.34 17 −1.4 ± 2.4 (−6.7–2.0) 0.09 20 −1.4 ± 3.4 (−8.7–6.0) 0.07 18 −0.3 ± 2.8 (−6.9–4.0) 0.90
Correlation of NEFL n R p n R p n R p n R p
With age 14 0.76 0.002 21 −0.24 0.30 21 0.54 0.01 20 0.15 0.53
With calf muscle FF 14 0.63 0.02 21 −0.62 0.003 19 0.25 0.30 19 0.15 0.54

Baseline and annualised change values, and Spearman rank correlation with age and fat fraction are given in patient and control groups. p‐Value for baseline patient values are compared with control (Tukey HSD), while for change values are paired Student t‐tests.